Related references
Note: Only part of the references are listed.The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
Takanori Yamazaki et al.
HYPERTENSION RESEARCH (2012)
Design, Synthesis and Antifibrotic Activities of Carbohydrate-Modified 1-(Substituted aryl)-5-trifluoromethyl-2(1H) Pyridones
Qinghua Lou et al.
MOLECULES (2012)
Pirfenidone treatment of idiopathic pulmonary fibrosis
Arata Azuma
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2012)
Fluorofenidone Attenuates Tubulointerstitial Fibrosis by Inhibiting TGF-beta(1)-Induced Fibroblast Activation
Qiongjing Yuan et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Fluorofenidone inhibits Ang II-induced apoptosis of renal tubular cells through blockage of the Fas/FasL pathway
Wang-bin Ning et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
The Inhibitory Effect of Ginsan on TGF-β Mediated Fibrotic Process
Ji-Yeon Ahn et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy
Bing-xin Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
STY39, A NOVEL ALPHA-MELANOCYTE-STIMULATING HORMONE ANALOGUE, ATTENUATES BLEOMYCIN-INDUCED PULMONARY INFLAMMATION AND FIBROSIS IN MICE
Ping-bo Xu et al.
SHOCK (2011)
Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis
Jeong Sup Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Anti-fibrotic effect of thalidomide through inhibiting TGF-β-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in mice
Jung-Yoon Choe et al.
INFLAMMATION RESEARCH (2010)
Fluorofenidone protects mice from lethal endotoxemia through the inhibition of TNF-α and IL-1β release
Yiting Tang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells
Xin-Yan Zhao et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Bleomycin and its Role in Inducing Apoptosis and Senescence in Lung Cells - Modulating Effects of Caveolin-1
Michael Kasper et al.
CURRENT CANCER DRUG TARGETS (2009)
Fluorofenidone attenuates collagen I and transforming growth factor-β1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells
Zhang-Zhe Peng et al.
NEPHROLOGY (2009)
CARDIAC-SPECIFIC OVEREXPRESSION OF INSULIN-LIKE GROWTH FACTOR I (IGF-1) RESCUES LIPOPOLYSACCHARIDE-INDUCED CARDIAC DYSFUNCTION AND ACTIVATION OF STRESS SIGNALING IN MURINE CARDIOMYOCYTES
Peng Zhao et al.
SHOCK (2009)
Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo
Elena Tourkina et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Caveolin-1, transforming growth factor-β receptor internalization, and the pathogenesis of systemic sclerosis
Francesco Del Galdo et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis
Hironobu Ihn
JOURNAL OF DERMATOLOGICAL SCIENCE (2008)
Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
Xiao Mei Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure
Ken W. Lee et al.
CIRCULATION (2006)
Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts
H Ihn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β and thrombospondin
A Azuma et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)
The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis
B Manoury et al.
RESPIRATORY RESEARCH (2005)
MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis
K Yoshida et al.
JOURNAL OF PATHOLOGY (2002)
A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis
H Matsuoka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2002)
Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder
M Selman et al.
RESPIRATORY RESEARCH (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation
SN Iyer et al.
INFLAMMATION (2000)
Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway
H Ihn et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
